Stay updated on Nivolumab Plus Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedA new revision tag (Revision: v3.5.4) was added, and the prior revision (Revision: v3.5.3) plus related topics (Melanoma and MedlinePlus Genetics) were removed. This reflects metadata housekeeping rather than alterations to the study content or participant information.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedMelanoma is now listed as a condition on the page, and the related topics section now includes MedlinePlus Genetics. The revision label has been updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedFooter revision updated from v3.5.0 to v3.5.2. No study content or navigation changes observed.SummaryDifference0.0%

- Check38 days agoChange DetectedPadova, Italy, 35128 added to the locations and Padua, Italy, 35128 removed, updating the site listing to the Italian spelling.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded Melanoma as a topic on the page. Related topics now include MedlinePlus Genetics.SummaryDifference0.1%

- Check52 days agoChange DetectedNaples, Italy 80131 was added as a study location and Napoli, Italy 80131 was removed, with a revision update to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Melanoma Clinical Trial page.